Michael DiVecchia
Direttore operativo presso Elicio Therapeutics, Inc. (Old)
Profilo
Michael DiVecchia is currently working as the Vice President of Operations & Program Management at Elicio Therapeutics, Inc. (United States).
Previously, he held the position of Senior VP of Operations & Human Resources at Elicio Therapeutics, Inc. from 2022 to 2024.
He completed his undergraduate degree at Syracuse University.
Posizioni attive di Michael DiVecchia
| Società | Posizione | Inizio |
|---|---|---|
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Direttore operativo | - |
Precedenti posizioni note di Michael DiVecchia
| Società | Posizione | Fine |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Direttore operativo | 01/01/2024 |
Formazione di Michael DiVecchia
| Syracuse University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael DiVecchia
